Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith A Gilbert

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Pharmacogenetics and Genomics|February 26, 2015
Evaluation of CYP2D6 enzyme activity using a 13C-dextromethorphan breath test in women receiving adjuvant tamoxifenStephanie L Safgren, Vera J Suman, Matthew L Kosel, et al.
Cancer Chemotherapy and Pharmacology|May 6, 2010
Plasma pharmacokinetics and oral bioavailability of the 3,4,5,6-tetrahydrouridine (THU) prodrug, triacetyl-THU (taTHU), in miceJan H Beumer, Julie L Eiseman, Judith A Gilbert, et al.
Breast Cancer Research and Treatment|September 16, 2017
Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancerRoberto A Leon-Ferre, Mei-Yin Polley, Heshan Liu, et al.
The Journal of Clinical Investigation|May 17, 2013
The genomic landscape of small intestine neuroendocrine tumorsMichaela S Banck, Rahul Kanwar, Amit A Kulkarni, et al.
Breast Cancer Research and Treatment|January 3, 2021
A clinical calculator to predict disease outcomes in women with triple-negative breast cancerMei-Yin C Polley, Roberto A Leon-Ferre, Samuel Leung, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Pharmacogenetics and Genomics|February 26, 2015
Evaluation of CYP2D6 enzyme activity using a 13C-dextromethorphan breath test in women receiving adjuvant tamoxifenStephanie L Safgren, Vera J Suman, Matthew L Kosel, et al.
Cancer Chemotherapy and Pharmacology|May 6, 2010
Plasma pharmacokinetics and oral bioavailability of the 3,4,5,6-tetrahydrouridine (THU) prodrug, triacetyl-THU (taTHU), in miceJan H Beumer, Julie L Eiseman, Judith A Gilbert, et al.
Breast Cancer Research and Treatment|September 16, 2017
Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancerRoberto A Leon-Ferre, Mei-Yin Polley, Heshan Liu, et al.
The Journal of Clinical Investigation|May 17, 2013
The genomic landscape of small intestine neuroendocrine tumorsMichaela S Banck, Rahul Kanwar, Amit A Kulkarni, et al.
Breast Cancer Research and Treatment|January 3, 2021
A clinical calculator to predict disease outcomes in women with triple-negative breast cancerMei-Yin C Polley, Roberto A Leon-Ferre, Samuel Leung, et al.
Pageof 5